CPMD CANNAPHARMARX, INC. OTC · United States

CANNAPHARMARX, INC. (CPMD) news

CANNAPHARMARX, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker CPMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CANNAPHARMARX, INC. news

We have not published a story on CANNAPHARMARX, INC. yet. When there is news, it will appear here.

CANNAPHARMARX, INC. annual financials

Line	FY2025	FY2024
Revenue	$1.4 million	$820,137
Net income (loss)	-$11.1 million	-$9.9 million
Cash from operations	-$789,102	-$1.7 million
Cash and equivalents	$1,804	$2,156

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $555.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about CANNAPHARMARX, INC.

What is the ticker symbol of CANNAPHARMARX, INC.?

CANNAPHARMARX, INC. trades under the ticker CPMD on OTC.

Where is CANNAPHARMARX, INC. listed?

CANNAPHARMARX, INC. is listed on OTC.

Which country or territory is CANNAPHARMARX, INC. listed under?

Our directory records CANNAPHARMARX, INC. under United States.

Does aibio.space cover CANNAPHARMARX, INC.?

aibio.space lists CANNAPHARMARX, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was CANNAPHARMARX, INC.'s revenue last year?

$1.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is CANNAPHARMARX, INC. profitable?

CANNAPHARMARX, INC. reported a net loss of $11.1 million for the fiscal year ended Dec 31, 2025, and used $789,102 of cash in operations, per its annual report to the SEC.

How much cash does CANNAPHARMARX, INC. have?

$555 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: CANNAPHARMARX, INC.

Members talk about CANNAPHARMARX, INC. (CPMD). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CANNAPHARMARX, INC., newest first. Each line links the filing it comes from.

Aug 17, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
May 18, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:CPMD on TradingView.

Listing details

Company: CANNAPHARMARX, INC.
Ticker: CPMD
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction